Merck & Co Inc (MRK)

In the past 90 days, Merck & Co Inc. reported one insider trading transaction, with a total net value of -$352,723.12, all attributed to a sale by SVP Finance Dalton E. III, who sold 4,262 shares on April 25, 2025. This transaction occurred shortly after the company's earnings report on April 24, 2025, where earnings per share exceeded expectations by 4.23%. The stock has experienced a decline of 13.7% over the last 90 days, indicating a challenging market environment.
Stock chart
Ticker: MRK Exchange: NYS


Loading...
Purchase Sale Planned purchase Planned sale Net purchase Net sale Earnings
Earnings
 
Value bought

Past 90 days

 
Value sold

Past 90 days

 
Net insiders buying

Past 90 days

 
Trades (buy and sell)

Past 90 days

Abbreviations B: Buy, S: Sell, PP: Planned purchase, PS: Planned sale, O: Option / Other
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value
Number of shares Price Value Details
2025-04-29 2025-04-25 S Sale

Smart Dalton E. III

SVP Fin. - Global Controller

Officer
4,262 -35.4%
82.76
USD 352,723
4,262 -35.4% 82.76 USD 352,723
2025-02-20 2025-02-19 S Sale

Oosthuizen Johannes Jacobus

President, U.S. Market

Officer
8,500 -21.7%
84.09
USD 714,745
8,500 -21.7% 84.09 USD 714,745
2025-02-13 2025-02-13 S Sale

Williams David Michael

EVP,Chief Info&Digital Officer

Officer
6,000 -19.9%
85.34
USD 512,057
6,000 -19.9% 85.34 USD 512,057
2025-02-07 2025-02-06 B Purchase

THULIN INGE G

Non-Executive Director
2,833 +2832.9%
88.25
USD 250,000
2,833 +2832.9% 88.25 USD 250,000
2025-02-07 2025-02-06 S Sale

Downing Cristal N

Chief Comm. & Public Afrs Ofcr

Officer
2,361 -25.0%
88.76
USD 209,551
2,361 -25.0% 88.76 USD 209,551
2025-02-07 2025-02-05 B Purchase

BAKER DOUGLAS M JR

Non-Executive Director
15,000 +1500.0%
88.50
USD 1,327,500
15,000 +1500.0% 88.50 USD 1,327,500
2024-02-15 2024-02-14 S Sale

Litchfield Caroline

EVP & CFO

Officer
38,291 -42.9%
125.50
USD 4,805,521
38,291 -42.9% 125.50 USD 4,805,521
2024-02-15 2024-02-14 S Sale

Davis Robert M

Chairman, CEO & President

Executive Director
85,021 -19.6%
125.40
USD 10,661,574
85,021 -19.6% 125.40 USD 10,661,574
2024-02-15 2024-02-13 S Sale

Davis Robert M

Chairman, CEO & President

Executive Director
25,324 -6.8%
126.37
USD 3,200,277
25,324 -6.8% 126.37 USD 3,200,277
2024-02-15 2024-02-13 S Sale

Davis Robert M

Chairman, CEO & President

Executive Director
124,676 -25.0%
125.74
USD 15,677,147
124,676 -25.0% 125.74 USD 15,677,147
2024-02-14 2024-02-13 S Sale

Romanelli Joseph

President, Human Health Int?l

Officer
1,000 -4.9%
124.89
USD 124,888
1,000 -4.9% 124.89 USD 124,888
2024-02-12 2024-02-09 S Sale

Li Dean Y

Executive VP & President, MRL

Officer
14,702 -24.1%
125.50
USD 1,845,083
14,702 -24.1% 125.50 USD 1,845,083
2024-02-08 2024-02-07 S Sale

Williams David Michael

EVP,Chief Info&Digital Officer

Officer
1,451 -6.8%
127.57
USD 185,108
1,451 -6.8% 127.57 USD 185,108
2024-02-05 2024-02-02 S Sale

Oosthuizen Johannes Jacobus

President, U.S. Market

Officer
18,959 -44.8%
127.18
USD 2,411,111
18,959 -44.8% 127.18 USD 2,411,111
2024-02-02 2024-02-02 S Sale

MIZELL STEVEN

EVP, Chief HR Officer

Officer
50,694 -68.2%
126.65
USD 6,420,349
50,694 -68.2% 126.65 USD 6,420,349
2024-02-02 2024-02-02 S Sale

Zachary Jennifer

EVP, General Counsel

Officer
49,499 -63.0%
126.97
USD 6,284,779
49,499 -63.0% 126.97 USD 6,284,779
2023-11-13 2023-11-09 S Sale

Oosthuizen Johannes Jacobus

President, U.S. Market

Officer
2,081 -10.3%
102.38
USD 213,061
2,081 -10.3% 102.38 USD 213,061
2023-11-09 2023-11-08 S Sale

DeLuca Richard R.

EVP&Pres, Merck Animal Heallth

Officer
43,823 -28.2%
105.03
USD 4,602,668
43,823 -28.2% 105.03 USD 4,602,668
2023-08-15 2023-08-14 S Sale

MIZELL STEVEN

EVP, Chief HR Officer

Officer
4,250 -15.6%
109.01
USD 463,293
4,250 -15.6% 109.01 USD 463,293
2023-08-04 2023-08-03 S Sale

MIZELL STEVEN

EVP, Chief HR Officer

Officer
4,500 -14.2%
105.49
USD 474,701
4,500 -14.2% 105.49 USD 474,701
// ... existing code ...